Update in the Diagnosis and Staging of Lung Cancer

作者: José Vilar , Jeremy J. Erasmus

DOI: 10.1007/978-88-470-5752-4_1

关键词:

摘要: Primary lung cancer is the leading cause of mortality in world and its incidence expected to rise next several decades, especially more recently industrialized countries such as China. This high largely explained by fact that patients with often present advanced stage disease. Imaging important early detection clinical staging cancer. Indeed both therapeutic options management are a considerable degree dependent upon disease at presentation. Detailed knowlegde appropriate use imaging evaluation non-small cell (NSCLC) required avoid unnecessary procedures, excess radiation, redundant information. facilitated guidelines well participation multidisciplinary teams which radiologists, pathologists, pulmonologists, surgeons, medical radiation oncologists discuss reach consensus on individualized treatment. The main objective this chapter review basic concepts related detection, staging, follow-up NSCLC.

参考文章(50)
G W Boland, M J Lee, MAGNETIC RESONANCE IMAGING OF THE ADRENAL GLAND Critical Reviews in Diagnostic Imaging. ,vol. 36, pp. 115- 174 ,(1995)
Rafael Meza, Kevin ten Haaf, Chung Yin Kong, Ayca Erdogan, William C. Black, Martin C. Tammemagi, Sung Eun Choi, Jihyoun Jeon, Summer S. Han, Vidit Munshi, Joost van Rosmalen, Paul Pinsky, Pamela M. McMahon, Harry J. de Koning, Eric J. Feuer, William D. Hazelton, Sylvia K. Plevritis, Comparative analysis of 5 lung cancer natural history and screening models that reproduce outcomes of the NLST and PLCO trials Cancer. ,vol. 120, pp. 1713- 1724 ,(2014) , 10.1002/CNCR.28623
Ramón Rami-Porta, Vanessa Bolejack, John Crowley, David Ball, Jhingook Kim, Gustavo Lyons, Thomas Rice, Kenji Suzuki, Charles F Thomas Jr, William D Travis, Yi-Long Wu, Prognostic Factors Committee, None, The IASLC Lung Cancer Staging Project: Proposals for the Revisions of the T Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer Journal of Thoracic Oncology. ,vol. 2, pp. 990- 1003 ,(2007) , 10.1097/JTO.0B013E31811F4703
Tsuguo Naruke, Keiichi Suemasu, Shichiro Ishikawa, Lymph node mapping and curability at various levels of metastasis in resected lung cancer. The Journal of Thoracic and Cardiovascular Surgery. ,vol. 76, pp. 832- 839 ,(1978) , 10.1016/S0022-5223(19)39559-5
Hiroaki Nomori, Kenichi Watanabe, Takashi Ohtsuka, Tsuguo Naruke, Keiichi Suemasu, Kimiichi Uno, Evaluation of F-18 fluorodeoxyglucose (FDG) PET scanning for pulmonary nodules less than 3 cm in diameter, with special reference to the CT images. Lung Cancer. ,vol. 45, pp. 19- 27 ,(2004) , 10.1016/J.LUNGCAN.2004.01.009
Madeleine T. King, Patricia M. Kenny, Christine A. Pollicino, Jocelyn M. McLean, Brian C. McCaughan, Michael J. Fulham, Rosalie C. Viney, Michael J. Boyer, Randomized Controlled Trial of the Role of Positron Emission Tomography in the Management of Stage I and II Non-Small-Cell Lung Cancer Journal of Clinical Oncology. ,vol. 22, pp. 2357- 2362 ,(2004) , 10.1200/JCO.2004.04.126
Heber MacMahon, John H. M. Austin, Gordon Gamsu, Christian J. Herold, James R. Jett, David P. Naidich, Edward F. Patz, Stephen J. Swensen, Guidelines for Management of Small Pulmonary Nodules Detected on CT Scans: A Statement from the Fleischner Society Radiology. ,vol. 237, pp. 395- 400 ,(2005) , 10.1148/RADIOL.2372041887
Benjamin D. Kozower, Bryan F. Meyers, Carolyn E. Reed, David R. Jones, Paul A. Decker, Joe B. Putnam, Does positron emission tomography prevent nontherapeutic pulmonary resections for clinical stage IA lung cancer The Annals of Thoracic Surgery. ,vol. 85, pp. 1166- 1170 ,(2008) , 10.1016/J.ATHORACSUR.2008.01.018